Am I the only one that expected this announcement to be initial treatments starting? Management said in July that they had been preparing for 7 years. Now we get an announcement that they are working on a contract. This is 8 months after FDA approval to start the study. I feel like I am missing something.
You are not the only one. This is typical MO here--things don't go according to plan but the information is never shared with the shareholders. On the plus side, this hopefully shows that the trial may still occur. I wonder what the real story is on the scrapping of the first trial plans.